MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma
- 1 December 1999
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 58 (3) , 285-291
- https://doi.org/10.1023/a:1006326513176
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Matrix metalloproteinase-2 immunoreactive proteinCancer, 1998
- Locally Advanced Breast CancerThe Oncologist, 1996
- The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993. Equal value for patients younger and older than age 50 yearsCancer, 1995
- Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrenceInternational Journal of Cancer, 1994
- Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodiesInternational Journal of Cancer, 1994
- Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasisThe FASEB Journal, 1993
- Type IV collagenases in invasive tumorsBreast Cancer Research and Treatment, 1993
- Activity of type IV collagenases in benign and malignant breast diseaseBritish Journal of Cancer, 1993
- Adjuvant Systemic Therapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group’s Trials of Cyclophosphamide or CMF in Premenopausal and Tamoxifen in Postmenopausal PatientsPublished by Springer Nature ,1984
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957